Exagen (XGN) Treasury Shares (2018 - 2019)

Exagen (XGN) has 8 years of Treasury Shares data on file, last reported at $2.1 million in Q1 2026.

• Quarterly Treasury Shares rose 16.85% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 16.85% YoY) and the FY2025 annual result came in at $1.8 million, up 4.99% from the prior year.
• Treasury Shares advanced to $2.1 million in Q1 2026, from $1.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.1 million in Q1 2026 to a low of $784940.0 in Q2 2022.
• A 5-year average of $1.5 million and a median of $1.7 million in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 374.91% — and 2025, when it slipped 2.52%.
• Tracing XGN's Treasury Shares over 5 years: stood at $1.0 million in 2022, then jumped by 33.9% to $1.4 million in 2023, then increased by 23.27% to $1.7 million in 2024, then advanced by 4.99% to $1.8 million in 2025, then increased by 18.6% to $2.1 million in 2026.
• The last three Treasury Shares figures came in at $2.1 million (Q1 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.